Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PeopleBio is a South Korean biotechnology company specializing in the development of blood-based diagnostic kits for neurodegenerative diseases. The company's core technology, the Multimer Detection System (MDS), is designed to detect protein multimers, which are key biomarkers for diseases such as Alzheimer's and Parkinson's, with high sensitivity in human blood. Their flagship product, the AlzOn blood test, measures oligomeric amyloid-beta to assist in the early detection of Alzheimer's disease. PeopleBio is actively expanding its diagnostic portfolio to include other protein misfolding disorders and is pursuing global commercialization through partnerships in Europe and Southeast Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on People Management.